Optimized Ruthenium-Catalyzed Synthesis of a Key Rimegepant Intermediate

Achieving high yield, purity, and enantioselectivity in pharmaceutical intermediate production.

Get a Quote & Sample

Advantages Offered

Enhanced Enantioselectivity

Our optimized process for Rimegepant intermediate production guarantees superior enantioselectivity, a crucial factor for the efficacy of the final drug.

Manufacturing Scale-Up

We excel in the scalable synthesis of Rimegepant intermediate, ensuring reliable supply for large-scale pharmaceutical manufacturing.

Process Cost Efficiency

The adopted Ruthenium-catalyzed ATH reaction for Rimegepant intermediate is designed for cost-effective Rimegepant intermediate synthesis, offering economic advantages.

Key Applications

Migraine Treatment Drug Synthesis

This intermediate is a cornerstone in the manufacturing of Rimegepant, a novel treatment for migraines.

CGRP Antagonist Development

Essential for producing calcitonin gene-related peptide antagonists, targeting a key pathway in pain management.

Advanced Pharmaceutical Research

Supports ongoing research and development in new therapeutic areas by providing a high-quality building block.

Custom Chemical Synthesis

Serves as a foundational compound for various custom chemical synthesis projects requiring precise stereochemistry.